InspireMD, Inc. - 8-K Filing

InspireMD receives FDA approval for CGuard Prime TransCarotid Stent System, doubling its U.S. total addressable market. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:45 UTC

Tickers: $NSPR

Read the full article at SEC EDGAR

Part of the story InspireMD, Inc. - 8-K Filing (2 articles)

More Regulatory news

SCHWAB CHARLES CORP - 8-K Filing SEC EDGAR · November 12, 2026, 21:52 UTC
SPRUCE POWER HOLDING CORP - 8-K Filing SEC EDGAR · November 12, 2026, 21:52 UTC
Xterax Corp II - 10-Q Filing SEC EDGAR · November 12, 2026, 21:51 UTC
KinderCare Learning Companies, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:50 UTC
Finwise Bancorp - 8-K Filing SEC EDGAR · November 12, 2026, 21:49 UTC
TMC the metals Co Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:48 UTC
FACT II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Marblegate Capital Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Greenland Mines Ltd - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC